The success of GLP-1R-targeting drugs highlights their viability as a treatment approach. Currently, there are four ...

Eli Lilly topped the list of the 20 biggest pharmas by market cap with a more than 39% improvement year-to-date in its share ...

Mounjaro is a treatment for Type 2 diabetes that activates GIP and GLP-1 pathways to help regulate blood sugar. It’s part of ...

Shares of Eli Lilly LLY and Novo Nordisk NVO were up on Tuesday, likely due to a proposal by President Biden that Medicare ...

The Biden administration is proposing that Medicare and Medicaid pay for popular anti-obesity drugs for more Americans.

Pharmaceutical stocks make great additions to any portfolio in any market environment. A good one promises steady revenue ...

It’s unclear what impact a change in presidential administration will have on the proposal to widen access for those with obesity.

The Biden administration plans to require Medicare and Medicaid to offer coverage of weight loss medications for people seeking obesity treatment.The new rule, which was proposed by the administration ...

The Biden administration is proposing a rule that would require the US government to cover weight-loss drugs, potentially ...

Share on Facebook Share on Twitter Under a new rule the Biden administration proposed on Tuesday, millions of Americans with ...

The microbial therapeutic products market is forecast to grow from USD 17.11 billion in 2022 to USD 30.55 billion by 2030, ...

Millions of obese Americans would get access to popular weekly injectables that would help them shed pounds quickly if a $35 ...